Skip to main content

Advertisement

SpringerLink
Log in

Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Skeletal muscle catabolism, low plasma glutamine, and high venous glutamate levels are common among patients with cancer or human immunodeficiency virus infection. In addition, a high glycolytic activity is commonly found in muscle tissue of cachectic cancer patients, suggesting insufficient mitochondrial energy metabolism. We therefore investigated (a) whether an “anaerobic physical exercise” program causes similar changes in plasma amino acid levels, and (b) whether low plasma glutamine or high glutamate levels are risk factors for loss of body cell mass (BCM) in healthy human subjects, i.e., in the absence of a tumor or virus infection. Longitudinal measurements from healthy subjects over longer periods suggest that the age-related loss of BCM occur mainly during episodes with high venous glutamate levels, indicative of decreased muscular transport activity for glutamate. A significant increase in venous glutamate levels from 25 to about 40 μM was seen after a program of “anaerobic physical exercise.” This was associated with changes in T lymphocyte numbers. Under these conditions persons with low baseline levels of plasma glutamine, arginine, and cystine levels also showed a loss of BCM. This loss of BCM was correlated not only with the amino acid levels at baseline examination, but also with an increase in plasma glutamine, arginine, and cystine levels during the observation period, suggesting that a loss of BCM in healthy individuals terminates itself by adjusting these amino acids to higher levels that stabilize BCM. To test a possible regulatory role of cysteine in this context we determined the effect of N-acetyl-cysteine on BCM in a group of subjects with relatively low glutamine levels. The placebo group of this study showed a loss of BCM and an increase in body fat, suggesting that body protein had been converted into other forms of chemical energy. The decrease in mean BCM/body fat ratios was prevented by N-acetyl-cysteine, indicating that cysteine indeed plays a regulatory role in the physiological control of BCM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

BCM :

Body cell mass

HIV :

Human immunodeficiency virus type 1

NAC :

N-Acetyl-cysteine

References

  1. Pisters PW, Pearlstone DB (1993) Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. Crit Rev in Clin Lab Sciences 30:223–272

    Google Scholar 

  2. Brennan MF (1986) Malnutrition in patients with gastrointestinal malignancy. Significance and management. Dig Dis Sci 31:77S-90S

    Google Scholar 

  3. Strain AJ (1979) Cancer cachexia in man. A review. Invest Cell Pathol 2:181–193

    Google Scholar 

  4. DeWys WD, Begg C, Lavin PT et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491–497

    Google Scholar 

  5. Grunfeld C (1991) Mechanisms of wasting in infection and cancer: an approach to cachexia in AIDS. In: Kotler DP (ed) Gastrointestinal and nutritional manisfestions of AIDS. Raven, New York, pp 207–229

    Google Scholar 

  6. Kotler DP, Wang J, Pierson R (1985) Body composition in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 42:1255–1265

    Google Scholar 

  7. Brennan MF (1977) Uncomplicated starvation versus cancer cachexia. Cancer Res 37:2359–2364

    Google Scholar 

  8. Long CL, Crosby F, Geiger JW, Kinney JM (1976) Parenteral nutrition in the septic patient: nitrogen balance, limiting plasma amino acids, and calorie to nitrogen ratios. Am J Clin Nutr 29:380–391

    Google Scholar 

  9. Fein R, Kelsen DP, Geller N (1985) Adenocarcinoma of the esophagus and gastroesophageal junction: prognostic factors and results of therapy. Cancer 56:2512–2518

    Google Scholar 

  10. Warren S (1932) The immediate causes of death in cancer. Am J Med Sci 184:610–615

    Google Scholar 

  11. Harnett WL (1952) A survey of cancer in London. British Empire Cancer Campaign

  12. Lawson DH, Richmond A, Nixon DW, Rudman D (1982) Metabolic approaches to cancer cachexia. Annu Rev Nutr. 2:277–301

    Google Scholar 

  13. Friedman PJ (1987) Is wasting itself lethal? A case-control prospective study. Nutr Res 7:707–717

    Google Scholar 

  14. Waterhouse C, Jeanpretre N, Kielson J (1968) Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 39: (1968)

  15. Shaw JH, Wolfe RR (1987) Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion and TPN Surgery 101:181–186

    Google Scholar 

  16. Shaw JHF, Klein S, Wolfe RR (1985) Assessment of alanine, urea and glucose interrelationships in normal subjects and in patients with sepsis using stable isotopic tracers. Surgery 97:557–567

    Google Scholar 

  17. Aoki T, Muller WA, Cahill GF (1972) Hormonal regulation of glutamine metabolism in fasting man. Adv Enzyme Regul 10:145–151

    Google Scholar 

  18. Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF (1969) Liver and kidney metabolism during prolonged starvation. J Clin Invest 48:584–594

    Google Scholar 

  19. Burt ME, Aoki TT, Gorschboth CM, Brennan MF (1983) Peripheral tissue metabolism in cancer-bearing man. Ann Surg 198:685–691

    Google Scholar 

  20. Striebel J-P, Saeger H-D, Ritz R, Leweling H, Holm E (1986) Aminosäureaufnahme und -abgabe kolorektaler Karzinome des Menschen. Infusionsther 13:92–104

    Google Scholar 

  21. Zhang PC, Pang CP (1992) Plasma amino acid patterns in cancer. Clin Chem 38:1198–1199

    Google Scholar 

  22. Dröge W, Groß A, Hack V, Kinscherf R, Schykowski M, Bockstette M, Mihm S, Galter D Role of cysteine and glutathione in HIV infection and cancer cachexia. — Therapeutic intervention with N-acetyl-cysteine (NAC). In: “Antioxidants in disease mechanisms and therapeutic strategies” (Sies H, ed.) Adv. Pharmacol, Acad Press, 1996 (in press)

  23. Dröge W, Eck H-P, Näher H, Pekar U, Daniel V (1988) Abnormal amino acid concentrations in the blood of patients with acquired immune deficiency syndrome (AIDS) may contribute to the immunological defect. Biol Chem Hoppe-Seyler 369:143–148

    Google Scholar 

  24. Hortin GL, Landt M, Powderly WG (1994) Changes in plasma amino acid concentrations in response to HIV-1 infection. Clin Chem 40:785–789

    Google Scholar 

  25. Roth E, Mühlbacher F, Karner J, Steininger R, Schemper M, Funovics, J (1985) Liver amino acids in sepsis. Surgery 97:436–442

    Google Scholar 

  26. Siegel JH, Cerra FB, Coleman B et al (1979) Physiological and metabolic correlations in human sepsis. Surgery 86:163–192

    Google Scholar 

  27. Cerra FB, Siegel JH, Coleman B (1980) Septic autocannibalism: a failure of exogenous nutritional support. Ann Surg 192:570–574

    Google Scholar 

  28. Roth E, Funovics J, Mühlbacher F, Schemper M, Mauritz W, Sporn P, Fritsch A (1982) Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr. 1:25–41

    Google Scholar 

  29. Klimberg VS, Souba WW, Salloum RM et al (1990) Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. J Surg Res 48:319–323

    Google Scholar 

  30. Scheltinga MR, Young LS, Benfell K, Bye RL, Ziegler TR, Santos AA, Antin JH, Schloerb PR, Wilmore DW (1991) Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress. Ann Surg 214:385–395

    Google Scholar 

  31. Stehle P, Mertes N, Puchstein Ch, Zander J, Albers S, Lawin P (1989) Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet I:231–233

    Google Scholar 

  32. Hammarqvist F, Wernerman J, Ali R, von der Decken A, Vinnars E (1989) Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis, and improves nitrogen balance. Ann Surg 209:455–461

    Google Scholar 

  33. Roth E, Karner J, Ollenschläger G, Karner J, Simmel A, Fürst P, Funovics J (1988) Alanylglutamine reduces muscle loss of alanine and glutamine in post-operative anaesthetized dogs. Clin Science 75:641–648

    Google Scholar 

  34. Tayek JA (1992) A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Col Nutr. 11:445–456

    Google Scholar 

  35. Wilmore DW, Aulick LH (1978) Metabolic changes in burned patients. Surg Clin North Am 58:1173–1187

    Google Scholar 

  36. Roth E (1985) Untersuchungen zum Aminosäuren- und Proteinstoffwechsel bei kritisch Kranken. Infusionstherapie 12:270–280

    Google Scholar 

  37. Eck H-P, Drings P, Droge W (1989) Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma. J Cancer Clin Oncol 115:571–574

    Google Scholar 

  38. Eck H-P, Stahl-Hennig C, Hunsmann G, Dröge W (1991) Metabolic disorder as an early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet 338:346–347

    Google Scholar 

  39. Plaitakis A, Caroscio JT (1987) Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 22:575–579

    Google Scholar 

  40. Hack V, Stütz O, Kinscherf R, Schykowski M, Kellerer M, Holm E, Droge W (1996) Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity. J Mol Med 74:337–343

    Google Scholar 

  41. Lukaski HC (1987) Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 46:537–556

    Google Scholar 

  42. Ott M, Lembcke B, Fischer H, Jäger R, Polat H, Geier H, Rech M, Staszeswki S, Helm EB, Caspary W (1993) Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 57:15–19

    Google Scholar 

  43. Askanazi J, Carpentier YA, Michelsen CB, Elwyn DH, Fürst P, Kantrowitz LR, Gump FE, Kinney JM (1980) Muscle and plasma amino acids following injury. Ann Surg 192:78–85

    Google Scholar 

  44. Fürst P, Bergström J, Chao L, Larsson J, Liljedahl S-O, Neuhäuser M, Schildt B, Vinnars E (1979) Influence of amino acid supply on nitrogen and amino acid metabolism in severe trauma. Acta Chir Scand Suppl 494:136

    Google Scholar 

  45. Barbul A (1986) Arginine: biochemistry, physiology and therapeutic implications. J Parent Ent Nutr 10:227–238

    Google Scholar 

  46. Daly JM, Reynolds JV, Thom A, Kinsley L, Dietrick-Gallagher M, Shou J, Ruggieri B (1988) Immune and metabolic effects of arginine in the surgical patient. Ann Surg 208:512–523

    Google Scholar 

  47. Kretschmar M, Müller D (1993) Aging, training and exercise. A review of effects on plasma glutathione and lipid peroxides. Sports Med 15:196–209

    Google Scholar 

  48. Häussinger D, Gerok W (1985) Hepatic urea synthesis and pH regulation. Role of CO2, HCO3−, pH and the activity of carbonic anhydrase. Eur J Biochem 152:381–386

    Google Scholar 

  49. Süttmann U, Hoogestraat L, Ockenga J, Coldewey R, Schedel I, Deicher H, Müller MJ (1991) Ernährungszustand und Immundefekt bei Patienten mit HIV-1-Infektion. Infusionstherapie 18:72–73

    Google Scholar 

  50. Süttmann U, Ockenga J, Seiberg O, Hoogestraat L, Deicher H, Muller, MJ (1995) Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr. Hum Retrovirol 8:239–246

    Google Scholar 

  51. Noakes TD (1986) The lore of running. Cape Town, Oxford University Press

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Immunochemistry, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany

    R. Kinscherf, V. Hack, T. Fischbach & W. Dröge

  2. Division of Biomedical Statistical Analysis, Deutsches Krebsforschungszentrum, D-69120, Heidelberg, Germany

    L. Edler

  3. Department of Sports Medicine, University of Heidelberg, D-69115, Heidelberg, Germany

    B. Friedmann, C. Weiss & P. Bärtsch

Authors
  1. R. Kinscherf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Hack
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Fischbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Friedmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Edler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Bärtsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W. Dröge
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kinscherf, R., Hack, V., Fischbach, T. et al. Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine. J Mol Med 74, 393–400 (1996). https://doi.org/10.1007/BF00210633

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00210633

Key words

Search

Navigation